Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2022 Earnings Call Transcript

Page 2 of 2

Operator: This concludes our question-and-answer session. I will now turn the call back to Dr. Mahadevia.

Ankit Mahadevia: Thank you, operator, and thanks to everyone who joined us on the call today to hear about our recent progress. We look forward to the continued advancement of our programs and wish everyone a nice evening.

Operator: This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation. Have a great day.

Follow Smartpros Ltd. (NASDAQ:SPRO)

Page 2 of 2